Mycoplasma pneumoniae beyond the COVID-19 pandemic: where is it?

Lancet Microbe. 2022 Dec;3(12):e897. doi: 10.1016/S2666-5247(22)00190-2. Epub 2022 Aug 11.

ESGMAC and the ESGMAC–MyCOVID study group:
Sabine Pereyre, Cécile Bébéar, Noémie Wagner, Corinne Andreutti, Gilbert Greub, Philipp K A Agyeman, Christoph Aebi, Michael Buettcher, Lisa Kottanattu, Valeria Gaia, Frank Imkamp, Reinhard Zbinden, Semjon Sidorov, Anita Niederer-Loher, Florence Barbey, Adrian Egli, Ulrich Heininger, Chloé Schlaeppi, Cihan Papan, Malte Kohns Vasconcelos, Birgit Henrich, Colin Mackenzie, Roger Dumke, Gerlinde Schneider, Nathalie Bossuyt, Melissa Vermeulen, Katherine Loens, Mireille van Westreenen, Nelianne J Verkaik, Annemarie M C van Rossum, Jessica Day, Baharak Afshar, Ville Peltola, Santtu Heinonen, Marjo Renko, Terhi Tapiainen, Henrik Døllner, Fernanda Rodrigues, Minos Matsas, Eleni Kalogera, Evangelia Petridou, Ioannis Kopsidas, Theoklis E Zaoutis, Darja Keše, Hila Elinav, Ayelet Michael-Gayego, Ho Namkoong, Yu-Chia Hsieh, Matthias Maiwald, Liat Hui Loo, Rama Chaudhry, Larry K Kociolek, Nadia Rodríguez, David Lorenz, Matthew Blakiston

¹ Division of Infectious Diseases and Hospital Epidemiology, University Children's Hospital Zurich, Zurich 8032, Switzerland. Electronic address: patrick.meyersauteur@kispi.uzh.ch.
² United Kingdom Health Security Agency, London, UK.
³ Division of Infectious Diseases and Hospital Epidemiology, University Children's Hospital Zurich, Zurich 8032, Switzerland.
⁴ Department of Clinical Microbiology and Infectious Diseases, Hadassah Hebrew University Medical Center, Jerusalem, Israel.
⁵ Microbiology and Infection Research Group, Department of Biomedical Sciences, Cardiff Metropolitan University, Cardiff, UK.

No abstract available

Publication types